Levosimendan Increases Bleeding Risk After Heart Valve Surgery: A Retrospective Analysis of a Randomized Trial
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function;Eriksson;Ann Thorac Surg,2009
2. Levosimendan reduces cardiac troponin release after cardiac surgery: A meta-analysis of randomized controlled studies;Zangrillo;J Cardiothorac Vasc Anesth,2009
3. Effect of levosimendan on survival and adverse events after cardiac surgery. A meta-analysis;Harrison;J Cardiothorac Vasc Anesth,2013
4. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery;Tritapepe;Br J Anaesth,2009
5. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan;Haikala;J Mol Cell Cardiol,1995
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of topical application of autologous platelet gel on sternal wound infection after cardiac surgery: A meta‐analysis;International Wound Journal;2024-02-29
2. Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study;International Journal of Molecular Sciences;2024-02-02
3. The effects of levosimendan in patients undergoing transcatheter aortic valve replacement- a retrospective analysis;Frontiers in Pharmacology;2022-11-03
4. Qili Qiangxin as an Adjuvant Treatment with Inotrope for Advanced Heart Failure: Retrospective Analysis;International Journal of Pharmacology;2022-02-01
5. Levosimendan administration is not associated with increased risk of bleeding and blood transfusion requirement in patients undergoing off-pump coronary artery bypass grafting: a retrospective study from single center;Perfusion;2021-10-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3